TGFB1 and neoplasm: Depending on different biological contexts, p38 MAPK inhibitors may prove to be useful as inhibitors of TGFβ-induced metastasis (by inhibiting EMT) or may prove less useful by promoting tumour proliferation through blocking TGFβ-induced apoptosis.